Prognostic factors and Doxorubicin involved in malignant progression of meningioma

Meningioma was the most primary intracranial tumor, but the molecular characteristics and the treatment of malignant meningioma were still unclear. Nine malignant progression-related genes based prognostic signatures were identified by transcriptome analysis between benign meningioma and malignant m...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Xulei, Song, Lairong, Wang, Ke, Wang, Hongyi, Li, Da, Li, Huan, Wang, Wei, Wang, Yali, Chen, Lei, Zhao, Zongmao, Wang, Liang, Wu, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079659/
https://www.ncbi.nlm.nih.gov/pubmed/37024523
http://dx.doi.org/10.1038/s41598-023-28996-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079659/
https://www.ncbi.nlm.nih.gov/pubmed/37024523
http://dx.doi.org/10.1038/s41598-023-28996-0

Ejemplares similares